Wasatch Advisors Inc C4 Therapeutics, Inc. Transaction History

Wasatch Advisors Inc

$19.9 Billion
Q4 2024

A detailed history of Wasatch Advisors Inc transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Wasatch Advisors Inc holds 6,072,601 shares of CCCC stock, worth $18.3 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

6,072,601

Previous 5,677,368 6.96%

Holding current value

$18.3 Million

Previous $32.4 Million 32.44%

% of portfolio

0.11%

Previous 0.16%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$3.6 - $7.0 $1.42 Million - $2.77 Million	395,233 Added 6.96%	6,072,601 $21.9 Million
Q3 2024 Nov 14, 2024	BUY	$4.43 - $7.38 $3.68 Million - $6.13 Million	830,218 Added 17.13%	5,677,368 $32.4 Million
Q2 2024 Aug 14, 2024	BUY	$4.05 - $8.1 $2.1 Million - $4.2 Million	518,671 Added 11.98%	4,847,150 $22.4 Million
Q1 2024 Apr 18, 2024	SELL	$5.3 - $11.0 $14.9 Million - $30.9 Million	-2,810,470 Reduced 39.37%	4,328,479 $35.4 Million
Q4 2023 Feb 14, 2024	BUY	$1.18 - $6.03 $1.05 Million - $5.38 Million	891,808 Added 14.28%	7,138,949 $40.3 Million
Q3 2023 Nov 14, 2023	SELL	$1.81 - $3.89 $1.72 Million - $3.7 Million	-952,350 Reduced 13.23%	6,247,141 $11.6 Million
Q2 2023 Aug 07, 2023	BUY	$2.75 - $3.77 $4.08 Million - $5.59 Million	1,483,470 Added 25.95%	7,199,491 $19.8 Million
Q1 2023 May 12, 2023	SELL	$3.1 - $9.02 $184,998 - $538,286	-59,677 Reduced 1.03%	5,716,021 $17.9 Million
Q4 2022 Feb 14, 2023	SELL	$5.42 - $10.24 $860,576 - $1.63 Million	-158,778 Reduced 2.68%	5,775,698 $34.1 Million
Q3 2022 Nov 14, 2022	BUY	$8.03 - $12.77 $2.15 Million - $3.42 Million	267,818 Added 4.73%	5,934,476 $52 Million
Q2 2022 Aug 12, 2022	BUY	$5.06 - $26.46 $20.9 Million - $109 Million	4,128,133 Added 268.32%	5,666,658 $42.7 Million
Q1 2022 May 13, 2022	BUY	$19.99 - $33.23 $4.86 Million - $8.08 Million	243,063 Added 18.76%	1,538,525 $37.3 Million
Q4 2021 Feb 15, 2022	SELL	$29.39 - $46.86 $1.37 Million - $2.18 Million	-46,585 Reduced 3.47%	1,295,462 $41.7 Million
Q3 2021 Nov 12, 2021	SELL	$35.91 - $50.5 $1.7 Million - $2.4 Million	-47,442 Reduced 3.41%	1,342,047 $60 Million
Q2 2021 Aug 12, 2021	BUY	$30.39 - $42.18 $9.25 Million - $12.8 Million	304,482 Added 28.06%	1,389,489 $52.6 Million
Q1 2021 May 10, 2021	BUY	$31.96 - $46.5 $34.7 Million - $50.5 Million	1,085,007 New	1,085,007 $40.1 Million

Others Institutions Holding CCCC

# of Institutions

126

Shares Held

63M

Call Options Held

651K

Put Options Held

115K

View Full List

About C4 Therapeutics, Inc.

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $147M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

More about CCCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wasatch Advisors Inc with notifications on news.

Account

Wasatch Advisors Inc C4 Therapeutics, Inc. Transaction History